Prophylactic somatostatin can reduce incidence of post-ERCP pancreatitis: multicenter randomized controlled trial
2015 · Endoscopy · 40 citations
https://doi.org/10.1055/s-0034-1391227
X
Xinjian Wan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
143
Papers
1.6K
Citations
22
h-index
50
i10-index
Xinjian Wan is an academic researcher from Shanghai International Studies University. The author has contributed to research in topics: Gallbladder and Bile Duct Disorders & Pediatric Hepatobiliary Diseases and Treatments & Cholangiocarcinoma and Gallbladder Cancer Studies. The author has an h-index of 22, co-authored 122 publications.
ORCID: 0000-0002-4201-633XPapers by this author
worksAmelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11
2024 · Cell Metabolism · 31 citations
https://doi.org/10.1016/j.cmet.2024.07.014
Efficacy of real-time artificial intelligence-aid endoscopic ultrasonography diagnostic system in discriminating gastrointestinal stromal tumors and leiomyomas: a multicenter diagnostic study
2024 · EClinicalMedicine · 17 citations
https://doi.org/10.1016/j.eclinm.2024.102656
Ganoderma lucidum polysaccharide ameliorates cholesterol gallstone formation by modulating cholesterol and bile acid metabolism in an FXR-dependent manner
2024 · Chinese Medicine · 16 citations
https://doi.org/10.1186/s13020-024-00889-y
HBx induces chemoresistance in diffuse large B cell lymphoma by inhibiting intrinsic apoptosis via the NF-κB/XIAP pathway
2024 · Molecular Therapy — Nucleic Acids · 4 citations
https://doi.org/10.1016/j.omtn.2024.102346
Peritumoral ductular reaction can be a prognostic factor for intrahepatic cholangiocarcinoma
2020 · BMC Gastroenterology · 3 citations
https://doi.org/10.1186/s12876-020-01471-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat